通过线粒体信号通路,用于癌症治疗的甲金属复合物的近期进展
Yunyun Zheng1, Hangyi An2, Jinxu Qi1
1Medical School of Pingdingshan University, Pingdingshan, China.
Frontiers in chemistry
|June 14, 2024
概括
西米卡巴金属复合物向细胞线粒体,诱导新型癌症治疗的细胞亡. 这篇评论详细介绍了它们的结构和通过线粒体通路的抗癌机制.
科学领域:
- 生物化学和分子生物学
- 药理学和毒理学 药理学和毒理学
- 癌症研究 癌症研究
背景情况:
- 线粒体对于细胞能量,细胞亡和新陈代谢调节至关重要,这使得它们成为癌症治疗的关键目标.
- 西米卡巴金属复合物正在通过向线粒体功能而成为有前途的抗癌药物.
- 破坏线粒体膜潜力会启动细胞亡,导致癌细胞死亡.
研究的目的:
- 检讨硫化甲金属复合物的结构多样性.
- 探索这些针对线粒体通路的复合体的抗癌机制.
- 突出其作为癌症治疗新型治疗剂的潜力.
主要方法:
- 关于硫化甲金属复合物的文献综述.
- 分析金属复合物的结构变化 (Fe (III),Cu (II),Ni (II),Zn (II),Ga (III),Pb (II),Au (III),Ir (III) 类).
- 检查针对线粒体通路的机制,包括膜潜在破坏和亡诱导.
主要成果:
- 西米卡巴金属复合物表现出显著的结构多样性.
- 这些复杂物有效地向线粒体,导致线粒体膜潜力的减少.
- 线粒体膜潜力的破坏会触发癌细胞中的亡.
结论:
- 硫甲金属复合物代表了一类有前途的抗癌药物.
- 它们的有效性与它们准和破坏线粒体功能的能力有关,从而诱导亡.
- 对这些复合物的进一步研究可能会导致创新的癌症治疗策略.
更多相关视频
19:44Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
Published on: May 30, 2012
18.7K
05:17Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay
Published on: February 9, 2021
1.5K
相关概念视频
Electron Transport Chain: Complex I and II
12.9K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
12.9K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
